Berberine Improves Cancer-Derived Myocardial Impairment in Experimental Cachexia Models by Targeting High-Mobility Group Box-1 DOI Open Access
Kei Goto,

Rina Fujiwara‐Tani,

Shota Nukaga

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(9), P. 4735 - 4735

Published: April 26, 2024

Cardiac disorders in cancer patients pose significant challenges to disease prognosis. While it has been established that these are linked cells, the precise underlying mechanisms remain elusive. In this study, we investigated impact of cancerous ascites from rat colonic carcinoma cell line RCN9 on H9c2 cardiomyoblast cells. We found reduced mitochondrial volume, increased oxidative stress, and decreased membrane potential leading apoptosis autophagy. Although fluid contained a substantial amount high-mobility group box-1 (HMGB1), observed neutralizing HMGB1 with specific antibody mitigated damage inflicted myocardial Our mechanistic investigations revealed activated both nuclear factor κB phosphoinositide 3-kinases-AKT signals through receptors, namely receptor for advanced glycation end products toll-like receptor-4, thereby promoting contrast, treatment berberine (BBR) induced expression miR-181c-5p miR-340-5p while suppressing Furthermore, BBR cardiomyocytes, consequently mitigating HMGB1-induced damage. validated protective effects cachectic model. These findings underscore strong association between cachexia, highlighting as promising therapeutic agent protection suppression modulation signaling system.

Language: Английский

Rodent model intervention for prevention and optimal management of sarcopenia: A systematic review on the beneficial effects of nutrients & non-nutrients and exercise to improve skeletal muscle health DOI Creative Commons
M. Vijayakumar,

Priya Kannappan,

Balakarthikeyan Janani

et al.

Ageing Research Reviews, Journal Year: 2024, Volume and Issue: unknown, P. 102543 - 102543

Published: Oct. 1, 2024

Language: Английский

Citations

1

Clinical and prognostic role of sarcopenia based on masticatory muscle index on MR images in patients with extranodal natural killer/T cell lymphoma, nasal type DOI
Tianzi Xu,

Yi Li,

Yixin Liu

et al.

Annals of Hematology, Journal Year: 2023, Volume and Issue: 102(12), P. 3521 - 3532

Published: Sept. 13, 2023

Language: Английский

Citations

2

Phytonutrients as Potential Dietary Supplements to Ameliorate Sarcopenia via the Involvement of Autophagic Pathway DOI
Yujie Sun,

Qingwei Zheng,

Juan Sun

et al.

Food Reviews International, Journal Year: 2023, Volume and Issue: 40(9), P. 2539 - 2579

Published: Nov. 12, 2023

Although sarcopenia has been a serious public health concern worldwide in recent years, its effective prevention and intervention measures are still lacking. The latest research found that autophagy dysfunction is an essential mechanism the pathogenesis of sarcopenia. And meanwhile, increasing studies have shown phytonutrients consumption positively correlated with maintenance skeletal muscle mass strength, which involves regulation pathway. However, due to opposite environmental-dependent effect sarcopenia, targeting by as treatment sometimes considered controversial. Thus, this review, based on illustration relationship between complex changes ameliorating regulating reviewed emphasis, possible underlying mechanisms systematically summarized. Despite some controversies, most current support idea maintaining basal functional contributes Several exhibit substantial beneficial effects autophagy, polyphenols (especially catechins urolithin A) be potentially clinical relevance. Hence, development promising approach complications.

Language: Английский

Citations

1

Molecular mechanisms underlying sarcopenia in heart failure DOI Open Access
Cody A Rutledge

The Journal of Cardiovascular Aging, Journal Year: 2023, Volume and Issue: 4(1)

Published: Dec. 27, 2023

The loss of skeletal muscle, also known as sarcopenia, is an aging-associated muscle disorder that disproportionately present in heart failure (HF) patients. HF patients with sarcopenia have poor outcomes compared to the overall patient population. prevalence only expected grow global population ages, and novel treatment strategies are needed improve this cohort. Multiple mechanistic pathways emerged may explain increased population, a better understanding these lead development therapies prevent loss. This review article aims explore molecular mechanisms linking HF, discuss aimed at addressing such signals.

Language: Английский

Citations

1

Berberine Improves Cancer-Derived Myocardial Impairment in Experimental Cachexia Models by Targeting High-Mobility Group Box-1 DOI Open Access
Kei Goto,

Rina Fujiwara‐Tani,

Shota Nukaga

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(9), P. 4735 - 4735

Published: April 26, 2024

Cardiac disorders in cancer patients pose significant challenges to disease prognosis. While it has been established that these are linked cells, the precise underlying mechanisms remain elusive. In this study, we investigated impact of cancerous ascites from rat colonic carcinoma cell line RCN9 on H9c2 cardiomyoblast cells. We found reduced mitochondrial volume, increased oxidative stress, and decreased membrane potential leading apoptosis autophagy. Although fluid contained a substantial amount high-mobility group box-1 (HMGB1), observed neutralizing HMGB1 with specific antibody mitigated damage inflicted myocardial Our mechanistic investigations revealed activated both nuclear factor κB phosphoinositide 3-kinases-AKT signals through receptors, namely receptor for advanced glycation end products toll-like receptor-4, thereby promoting contrast, treatment berberine (BBR) induced expression miR-181c-5p miR-340-5p while suppressing Furthermore, BBR cardiomyocytes, consequently mitigating HMGB1-induced damage. validated protective effects cachectic model. These findings underscore strong association between cachexia, highlighting as promising therapeutic agent protection suppression modulation signaling system.

Language: Английский

Citations

0